Skip to main content
. 2016 Jun 9;16:260. doi: 10.1186/s12879-016-1615-y

Table 4.

Sensitivity and specificity of HRM analysis in comparison with Drug susceptibility

Drug Target HRM profile % variant Drug susceptibility % resistant Sensitivity (%) Specificity (%)
+ +
Rifampicin rpoB 79 88 47.3 78 89 46.7 98.7 (92.2–99.9) 97.75 (91.2–99.6)
Isoniazid katG and/or 77 90 46.1 78 89 46.7 98.7 (92.2–99.9) 100 (94.2–99.9)
inhA promoter